93 related articles for article (PubMed ID: 11854436)
1. Differential response of estrogen receptors alpha and beta to SP500263, a novel potent selective estrogen receptor modulator.
Brady H; Doubleday M; Gayo-Fung LM; Hickman M; Khammungkhune S; Kois A; Lipps S; Pierce S; Richard N; Shevlin G; Sutherland MK; Anderson DW; Bhagwat SS; Stein B
Mol Pharmacol; 2002 Mar; 61(3):562-8. PubMed ID: 11854436
[TBL] [Abstract][Full Text] [Related]
2. Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models.
Brady H; Desai S; Gayo-Fung LM; Khammungkhune S; McKie JA; O'Leary E; Pascasio L; Sutherland MK; Anderson DW; Bhagwat SS; Stein B
Cancer Res; 2002 Mar; 62(5):1439-42. PubMed ID: 11888917
[TBL] [Abstract][Full Text] [Related]
3. Lead identification of a potent benzopyranone selective estrogen receptor modulator.
McKie JA; Bhagwat SS; Brady H; Doubleday M; Gayo L; Hickman M; Jalluri RK; Khammungkhune S; Kois A; Mortensen D; Richard N; Sapienza J; Shevlin G; Stein B; Sutherland M
Bioorg Med Chem Lett; 2004 Jul; 14(13):3407-10. PubMed ID: 15177442
[TBL] [Abstract][Full Text] [Related]
4. Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
Sutherland MK; Brady H; Gayo-Fung LM; Leisten J; Lipps SG; McKie JA; O'Leary E; Patnaik N; Anderson DW; Bhagwat SS; Stein B
Calcif Tissue Int; 2003 Jun; 72(6):710-6. PubMed ID: 14563000
[TBL] [Abstract][Full Text] [Related]
5. SP500263, a novel SERM, blocks osteoclastogenesis in a human bone cell model: role of IL-6 and GM-CSF.
Kung Sutherland MS; Lipps SG; Patnaik N; Gayo-Fung LM; Khammungkune S; Xie W; Brady HA; Barbosa MS; Anderson DW; Stein B
Cytokine; 2003 Jul; 23(1-2):1-14. PubMed ID: 12901849
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
7. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
[TBL] [Abstract][Full Text] [Related]
8. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
9. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
Zhang CC; Krieg S; Shapiro DJ
Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
11. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
12. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
13. [Estrogen receptor and selective estrogen receptor modulators (SERMs)].
Shioi A; Nishizawa Y
Nihon Rinsho; 1999 May; 57(5):1199-207. PubMed ID: 10361456
[TBL] [Abstract][Full Text] [Related]
14. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
15. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.
Sun J; Meyers MJ; Fink BE; Rajendran R; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 1999 Feb; 140(2):800-4. PubMed ID: 9927308
[TBL] [Abstract][Full Text] [Related]
16. Differential transcriptional regulation of rat vasopressin gene expression by estrogen receptor alpha and beta.
Shapiro RA; Xu C; Dorsa DM
Endocrinology; 2000 Nov; 141(11):4056-64. PubMed ID: 11089536
[TBL] [Abstract][Full Text] [Related]
17. Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator.
Zhang JX; Labaree DC; Mor G; Hochberg RB
J Clin Endocrinol Metab; 2004 Jul; 89(7):3527-35. PubMed ID: 15240642
[TBL] [Abstract][Full Text] [Related]
18. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
19. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
20. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta.
Watanabe T; Inoue S; Ogawa S; Ishii Y; Hiroi H; Ikeda K; Orimo A; Muramatsu M
Biochem Biophys Res Commun; 1997 Jul; 236(1):140-5. PubMed ID: 9223441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]